HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
José Ernesto VidalCamila de Albuquerque MoraesRenata Elisie Barbalho de SiqueiraNathalya Fernanda Brito MirandaRosa MarcussoDavid R BoulwareAugusto C Penalva de OliveiraPublished in: Mycopathologia (2020)
In this "real-world" study, amphotericin plus flucytosine shows low early mortality of patients with HIV-associated cryptococcal meningitis. Early discontinuation due to adverse events was moderate. More effective and safe antifungals are needed in order to improve the outcome of cryptococcal meningitis.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv testing
- hiv infected
- cerebrospinal fluid
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- men who have sex with men
- healthcare
- palliative care
- primary care
- cardiovascular events
- south africa
- high intensity
- clinical practice
- risk factors
- pain management
- affordable care act
- health insurance